SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-100517
Filing Date
2008-05-02
Accepted
2008-05-02 14:11:19
Documents
6
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 399208
2 AMENDMENT NO. 1 TO COMMON STOCK PURCHASE AGREEMENT dex1035.htm EX-10.35 7870
3 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 10604
4 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 10623
5 CERTIFICATION OF CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 5381
6 CERTIFICATION OF CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 5400
  Complete submission text file 0001193125-08-100517.txt   440516
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50577 | Film No.: 08798140
SIC: 2834 Pharmaceutical Preparations